Quaker Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.8K Sell
352
-29
-8% -$4.45K 0.02% 158
2025
Q4
$52.5K Buy
381
+29
+8% +$3.8K 0.02% 161
2025
Q3
$45.1K Hold
352
0.01% 173
2025
Q2
$42.6K Buy
+352
New +$39.7K 0.01% 172

Other funds holding NVS

Quaker Wealth Management's NVS Position: Q1 2026 in Review

Quaker Wealth Management reduced its Novartis (NVS) stake by 7.6% in Q1 2026, selling an estimated $4.45K and leaving 352 shares worth $53.8K. The position accounts for 0.02% of the portfolio, ranked #158.

Quaker Wealth Management first reported a position in NVS in Q2 2025 and has held it in 4 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Quaker Wealth Management held 352 shares of Novartis worth $53.8K as of Q1 2026.
  • Quaker Wealth Management sold 29 Novartis shares in Q1 2026, an estimated $4.45K.
  • Novartis made up 0.02% of Quaker Wealth Management's portfolio in Q1 2026, its #158 holding.
  • Quaker Wealth Management first reported a position in Novartis in Q2 2025 and has held it in 4 quarters since.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Quaker Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.